Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer

Details for Australian Patent Application No. 2002330177 (hide)

Owner The General Hospital Corporation

Inventors Fishman, Mark C; Rottbauer, Wolfgang

Agent Pizzeys

Pub. Number AU-B-2002330177

PCT Number PCT/US02/31234

PCT Pub. Number WO2003/028537

Priority 60/326,646 01.10.01 US

Filing date 1 October 2002

Wipo publication date 14 April 2003

Acceptance publication date 26 June 2008

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/00 (2006.01)

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/46 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/26 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 60/326,646 01.10.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002330177

26 June 2008 Application Accepted

  Published as AU-B-2002330177

30 October 2008 Standard Patent Sealed

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002330178-SYSTEM, APPARATUS, AND METHOD FOR FACILITATING POINTOF-SALE TRANSACTIONS

2002330176-Identification of genes involved in restenosis and in atherosclerosis